FDA Adverse Event Injury Summary report: N

XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 1243776 · Received November 24, 2008

Report

Report Number
2024168-2008-01219
Event Type
Injury
Date Received
November 24, 2008
Date of Event
October 27, 2008
Report Date
October 30, 2008
Manufacturer
ABBOTT VASCULAR-CARDIAC THERAPIES
Product Code
NIQ
PMA / PMN Number
P070015
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IT
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

RESULTS AND CONCLUSION SUMMATION - PRODUCT PERFORMANCE ENGINEERING REVIEWED THE INCIDENT. DISSECTION AND ISCHEMIA ARE KNOWN PATIENT EFFECTS ASSOCIATED WITH CORONARY ARTERY STENTING PROCEDURES, AND BOTH ARE LISTED AS POTENTIAL ADVERSE EVENTS IN THE DEVICE INSTRUCTIONS FOR USE. IN THIS CASE, THERE WERE NO DIFFICULTIES REPORTED DEPLOYING THE STENT IMPLANT DURING THE PROCEDURE, AND NO DAMAGE WAS NOTED TO THE STENT DELIVERY SYSTEM PRIOR TO OR AFTER USE. THUS, ALTHOUGH THERE ARE NO INDICATIONS OF A PRODUCT QUALITY ISSUE AFFECTING THE OUTCOME OF THE PROCEDURE, A DEFINITE ROOT CAUSE FOR THE DISSECTION AND ISCHEMIA CAN BE DETERMINED.

Description of Event or Problem · 1

REPORTING STATUS: SERIOUS INJURY/MEDICAL INTERVENTION. REPORTING RATIONALE: DISSECTION REQUIRING MEDICAL INTERVENTION. DEVICE ISSUE: NO DEVICE MALFUNCTION HAS BEEN REPORTED. IT WAS REPORTED VIA TRAIL THAT PREDILATATION WAS PERFORMED PRIOR TO STENTING. A XIENCE V STENT WAS IMPLANTED IN THE MID RCA (3.0 X 28 MM) AND THE PROCEDURE WAS ENDED. POST PROCEDURE, THE PATIENT SHOWED SYMPTOMS OF ISCHEMIA AND A REPEAT ANGIOGRAPHY SHOWED THAT A DISSECTION HAD OCCURRED DISTAL TO THE IMPLANTED STENT. TWO ADDITIONAL XIENCE V STENTS WERE USED TO TREAT THE DISSECTION. NO ADDITIONAL EVENT OR PATIENT INFORMATION IS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM NIQ ABBOTT VASCULAR-CARDIAC THERAPIES NA UNK

Patients

Seq Age Sex Outcome Treatment
1 64 YR Required Intervention